Abstract
Cytokines produced by T lymphocytes are critical to the efficacy of a given immune response and dysregulation of immune responses may play a role in cancer progression. We assessed the intracellular cytokine profiles of T cells in the peripheral blood of women with breast cancer and explored the relationship of these responses with the presence of cancer in lymph nodes and bone marrow. Peripheral blood lymphocytes from 84 patients and 26 healthy volunteers were analyzed by 4-color flow cytometry for surface markers and for intracellular cytokines. Bone marrow samples from some of these patients were also collected and analyzed for the presence of epithelial cells (micrometastases) by flow cytometry. The percentages of both CD4+ and CD8+ cells producing type1 (IL-2, IFN-γ or TNF-α) and type 2 (IL-4) were significantly lower in patients with breast cancer compared to healthy controls. These results indicate a general immune dysfunction in these patients as opposed to a shift in the balance of type1 and type2 cells. These dysregulated T cell responses did not correlate with age, stage of disease, or nodal status. However, we did observe a correlation between number of micrometastases in the bone marrow and T cell responsiveness.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
P Pellegrini AM Berghella T Del Beato S Cicia D Adorno CU Casciani (1996) ArticleTitleDisregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression Cancer Immunol Immunother 42 1–8 Occurrence Handle10.1007/s002620050244 Occurrence Handle1:STN:280:DyaK287psleltg%3D%3D Occurrence Handle8625361
E Angevin F Kremer C Gaudin T Hercend F Triebel (1997) ArticleTitleAnalysis of T-cell immune response in renal cell carcinoma: polarization to type 1-like differentiation pattern, clonal T-cell expansion and tumor-specific cytotoxicity Int J Cancer 72 431–440 Occurrence Handle10.1002/(SICI)1097-0215(19970729)72:3<431::AID-IJC10>3.0.CO;2-F Occurrence Handle1:CAS:528:DyaK2sXls1WgtLY%3D Occurrence Handle9247286
M Sato S Goto R Kaneko M Ito S Sato S Takeuchi (1998) ArticleTitleImpaired production of Th1 cytokines and increased frequency of Th2 subsets in PBMC from advanced cancer patients Anticancer Res 18 3951–3955 Occurrence Handle1:CAS:528:DyaK1MXjtVartA%3D%3D Occurrence Handle9854509
S Goto M Sato R Kaneko M Itoh S Sato S Takeuchi (1999) ArticleTitleAnalysis of Th1 and Th2 cytokine production by peripheral blood mononuclear cells as a parameter of immunological dysfunction in advanced cancer patients Cancer Immunol Immunother 48 435–442 Occurrence Handle10.1007/s002620050620 Occurrence Handle1:CAS:528:DyaK1MXns1aluro%3D Occurrence Handle10550548
T Tabata S Hazama S Yoshino M Oka (1999) ArticleTitleTh2 subset dominance among peripheral blood T lymphocytes in patients with digestive cancers Am J Surg 177 203–208 Occurrence Handle10.1016/S0002-9610(99)00004-5 Occurrence Handle1:STN:280:DyaK1M3jsFalsw%3D%3D Occurrence Handle10219855
N Ito H Nakamura Y Tanaka S Ohgi (1999) ArticleTitleLung carcinoma: analysis of T helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry Cancer 85 2359–2367 Occurrence Handle10.1002/(SICI)1097-0142(19990601)85:11<2359::AID-CNCR10>3.0.CO;2-A Occurrence Handle1:STN:280:DyaK1M3osVaqug%3D%3D Occurrence Handle10357406
XL Zhang Y Komada J Chipeta QS Li H Inaba E Azuma H Yamamoto M Sakurai (2000) ArticleTitleIntracellular cytokine profile of T cells from children with acute lymphoblastic leukemia Cancer Immunol Immunother 49 165–172 Occurrence Handle10.1007/s002620050616 Occurrence Handle1:CAS:528:DC%2BD3cXltFWmsLo%3D Occurrence Handle10881696
TR Mosmann RL Coffman (1989) ArticleTitleTH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties Annu Rev Immunol 7 145–173 Occurrence Handle10.1146/annurev.iy.07.040189.001045 Occurrence Handle1:CAS:528:DyaL1MXit12lsbk%3D Occurrence Handle2523712
S Romagnani (1991) ArticleTitleHuman TH1 and TH2 subsets: doubt no more Immunol Today 12 256–257 Occurrence Handle10.1016/0167-5699(91)90120-I Occurrence Handle1:STN:280:DyaK38%2FgtVWntw%3D%3D Occurrence Handle1680337
DR Lucey M Clerici GM Shearer (1996) ArticleTitleType 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases Clin Microbiol Rev 9 532–562 Occurrence Handle1:CAS:528:DyaK28XmsFOks78%3D Occurrence Handle8894351
S Romagnani (1997) ArticleTitleThe Th1/Th2 paradigm Immunol Today 18 263–266 Occurrence Handle10.1016/S0167-5699(97)80019-9 Occurrence Handle1:CAS:528:DyaK2sXktVKhtr4%3D Occurrence Handle9190109
S Romagnani P Parronchi MM D’Elios P Romagnani F Annunziato MP Piccinni R Manetti S Sampognaro C Mavilia M De Carli E Maggi GF Del Prete (1997) ArticleTitleAn update on human Th1 and Th2 cells Int Arch Allergy Immunol 113 153–156 Occurrence Handle1:STN:280:DyaK2s3ns1yitw%3D%3D Occurrence Handle9130508
R Punnonen K Teisala T Kuoppala B Bennett J Punnonen (1998) ArticleTitleCytokine production profiles in the peritoneal fluids of patients with malignant or benign gynecologic tumors Cancer 83 788–796 Occurrence Handle1:STN:280:DyaK1cznt1Kkug%3D%3D Occurrence Handle9708947
T Onishi Y Ohishi K Imagawa Y Ohmoto K Murata (1999) ArticleTitleAn assessment of the immunological environment based on intratumoral cytokine production in renal cell carcinoma BJU Int 83 488–492 Occurrence Handle1:STN:280:DyaK1M3hvFKgsQ%3D%3D Occurrence Handle10210576
L Lauerova L Dusek M Simickova I Kocak M Vagundova J Zaloudik J Kovarik (2002) ArticleTitleMalignant melanoma associates with Th1/Th2 imbalance that coincides with disease progression and immunotherapy response Neoplasma 49 159–166 Occurrence Handle1:CAS:528:DC%2BD38XlvFWjsbc%3D Occurrence Handle12098001
T Jung U Schauer C Heusser C Neumann C Rieger (1993) ArticleTitleDetection of intracellular cytokines by flow cytometry J Immunol Methods 159 197–207 Occurrence Handle1:CAS:528:DyaK3sXktVKlurY%3D Occurrence Handle8445253
LJ Picker MK Singh Z Zdraveski JR Treer SL Waldrop PR Bergstresser VC Maino (1995) ArticleTitleDirect demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry Blood 86 1408–1419 Occurrence Handle1:CAS:528:DyaK2MXnsVCltrw%3D Occurrence Handle7632949
VC Maino LJ Picker (1998) ArticleTitleIdentification of functional subsets by flow cytometry: intracellular detection of cytokine expression Cytometry 34 207–215 Occurrence Handle1:CAS:528:DyaK1cXnsVCgurw%3D Occurrence Handle9822306
MA Suni LJ Picker VC Maino (1998) ArticleTitleDetection of antigen-specific T cell cytokine expression in whole blood by flow cytometry J Immunol Methods 212 89–98 Occurrence Handle1:CAS:528:DyaK1cXjtVKlsbs%3D Occurrence Handle9671156
HT Maecker VC Maino LJ Picker (2000) ArticleTitleImmunofluorescence analysis of T-cell responses in health and disease J Clin Immunol 20 391–399 Occurrence Handle1:STN:280:DC%2BD3M3gt1WgsQ%3D%3D Occurrence Handle11202228
SA Ghanekar HT Maecker (2003) ArticleTitleCytokine flow cytometry: multiparametric approach to immune function analysis Cytotherapy 5 1–6 Occurrence Handle1:CAS:528:DC%2BD3sXjtFGisLk%3D Occurrence Handle12745590
M Akimoto H Ishii Y Nakajima H Iwasaki M Tan R Abe M Kasai (1986) ArticleTitleAssessment of host immune response in breast cancer patients Cancer Detect Prev 9 311–317 Occurrence Handle1:STN:280:DyaL283pvVahsA%3D%3D Occurrence Handle3488806
JF Head RL Elliott JL McCoy (1993) ArticleTitleEvaluation of lymphocyte immunity in breast cancer patients Breast Cancer Res Treat 26 77–88 Occurrence Handle1:STN:280:DyaK2c%2FgtlemsQ%3D%3D Occurrence Handle8400326
C Wiltschke M Krainer AC Budinsky A Berger C Muller R Zeillinger P Speiser E Kubista M Eibl CC Zielinski (1995) ArticleTitleReduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study Br J Cancer 71 1292–1296 Occurrence Handle1:STN:280:DyaK2M3pvVKrsA%3D%3D Occurrence Handle7779726
A Nicolini P Ferrari R Spinelli A Carpi A Sagripanti F Ambrogi (1996) ArticleTitleCell-mediated immunity in breast cancer patients Biomed Pharmacother 50 337–343 Occurrence Handle1:STN:280:DyaK2s7htVOjsw%3D%3D Occurrence Handle8952852
JL Mccoy R Rucker JA Petros (2000) ArticleTitleCell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status Breast Cancer Res Treat 60 227–234 Occurrence Handle1:CAS:528:DC%2BD3cXlvVOksr0%3D Occurrence Handle10930110
A Nicolini A Carpi P Ferrari G Tartarelli L Anselmi MR Metelli I Gorini C Spinelli P Miccoli R Giardino (2002) ArticleTitleLong-term monitoring of cell-mediated immunity in disease-free breast cancer patients: a preliminary retrospective study Biomed Pharmacother 56 339–344 Occurrence Handle1:STN:280:DC%2BD38nlvVCnsA%3D%3D Occurrence Handle12418581
M Kastelan M Rudolf M Hrsak R Stojkovic S Gamulin (1985) ArticleTitleLymphocyte reactivity to mitogens and tumor sex steroid receptors in breast cancer patients Biomed Pharmacother 39 442–444 Occurrence Handle1:STN:280:DyaL283hs1Ggtg%3D%3D Occurrence Handle3834952
SM Levy RB Herberman T Whiteside K Sanzo J Lee J Kirkwood (1990) ArticleTitlePerceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients Psychosom Med 52 73–85 Occurrence Handle1:STN:280:DyaK3c7mtFSjsQ%3D%3D Occurrence Handle2305024
SM Levy RB Herberman J Lee T Whiteside J Kirkwood S McFeeley (1990) ArticleTitleEstrogen receptor concentration and social factors as predictors of natural killer cell activity in early-stage breast cancer patients Confirmation of a model. Nat Immun Cell Growth Regul 9 313–324 Occurrence Handle1:CAS:528:DyaK3MXkvFSjs7Y%3D
WL Garner JP Minton AG James CC Hoffmann (1983) ArticleTitleHuman breast cancer and impaired NK cell function J Surg Oncol 24 64–66 Occurrence Handle1:STN:280:DyaL3s3psF2gsQ%3D%3D Occurrence Handle6887939
RL Elliott JF Head JL McCoy (1994) ArticleTitleComparison of estrogen and progesterone receptor status to lymphocyte immunity against tumor antigens in breast cancer patients Breast Cancer Res Treat 30 299–304 Occurrence Handle1:STN:280:DyaK2M%2Fnt1arsw%3D%3D Occurrence Handle7981448
C Wiltschke M Krainer AC Budinsky A Berger C Muller R Zeillinger P Speiser E Kubista M Eibl CC Zielinski (1995) ArticleTitleReduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study Br J Cancer 71 1292–1296 Occurrence Handle1:STN:280:DyaK2M3pvVKrsA%3D%3D Occurrence Handle7779726
RJ Cote PP Rosen ML Lesser LJ Old MP Osborne (1991) ArticleTitlePrediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases J Clin Oncol 9 1749–1756 Occurrence Handle1:STN:280:DyaK38%2FhsVWntQ%3D%3D Occurrence Handle1919627
JL Mansi D Easton U Berger JC Gazet HT Ford D Dearnaley RC Coombes (1991) ArticleTitleBone marrow micrometastases in primary breast cancer: prognostic significance after 6 years’ follow-up Eur J Cancer 27 1552–1555 Occurrence Handle1:STN:280:DyaK387ksVahsA%3D%3D Occurrence Handle1782061 Occurrence Handle10.1016/0277-5379(91)90413-8
N Harbeck M Untch L Pache W Eiermann (1994) ArticleTitleTumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up Br J Cancer 69 566–571 Occurrence Handle1:STN:280:DyaK2c7mvV2luw%3D%3D Occurrence Handle7510120
IJ Diel M Kaufmann SD Costa R Holle G Minckwitz Particlevon EF Solomayer S Kaul G Bastert (1996) ArticleTitleMicrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status J Natl Cancer Inst 88 1652–1658 Occurrence Handle1:STN:280:DyaK2s%2FosFCluw%3D%3D Occurrence Handle8931609
S Braun K Pantel P Muller W Janni F Hepp CR Kentenich S Gastroph A Wischnik T Dimpfl G Kindermann G Riethmuller G Schlimok (2000) ArticleTitleCytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer N Engl J Med 342 525–533 Occurrence Handle1:STN:280:DC%2BD3c7jt1ejsw%3D%3D Occurrence Handle10684910
E Maraskovsky WF Chen K Shortman (1989) ArticleTitleIL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells J Immunol 143 1210–1214 Occurrence Handle1:CAS:528:DyaL1MXlsFWks70%3D Occurrence Handle2501391
CS Hsieh SE Macatonia CS Tripp SF Wolf A O’Garra KM Murphy (1993) ArticleTitleDevelopment of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages Science 260 547–549 Occurrence Handle1:CAS:528:DyaK3sXitlajsLg%3D Occurrence Handle8097338
R Manetti P Parronchi MG Giudizi MP Piccinni E Maggi G Trinchieri S Romagnani (1993) ArticleTitleNatural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells J Exp Med 177 1199–1204 Occurrence Handle1:CAS:528:DyaK3sXhsVGkt7o%3D Occurrence Handle8096238
UK Liyanage TT Moore HG Joo Y Tanaka V Herrmann G Doherty JA Drebin SM Strasberg TJ Eberlein PS Goedegebuure DC Linehan (2002) ArticleTitlePrevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma J Immunol 169 2756–2761 Occurrence Handle1:CAS:528:DC%2BD38XmsF2ns7k%3D Occurrence Handle12193750
AM Wolf D Wolf M Steurer G Gastl E Gunsilius B Grubeck-Loebenstein (2003) ArticleTitleIncrease of regulatory T cells in the peripheral blood of cancer patients Clin Cancer Res 9 606–612 Occurrence Handle12576425
A Burford-Mason GM Gyte SM Watkins (1989) ArticleTitlePhytohaemagglutinin responsiveness of peripheral lymphocytes and survival in patients with primary breast cancer Breast Cancer Res Treat 13 243–250 Occurrence Handle1:STN:280:DyaL1MzjsF2huw%3D%3D Occurrence Handle2758113
C Wiltschke M Krainer AC Budinsky A Berger C Muller R Zeillinger P Speiser E Kubista M Eibl CC Zielinski (1995) ArticleTitleReduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study Br J Cancer 71 1292–1296 Occurrence Handle1:STN:280:DyaK2M3pvVKrsA%3D%3D Occurrence Handle7779726
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Campbell, M.J., Scott, J., Maecker, H.T. et al. Immune dysfunction and micrometastases in women with breast cancer. Breast Cancer Res Treat 91, 163–171 (2005). https://doi.org/10.1007/s10549-004-7048-0
Issue Date:
DOI: https://doi.org/10.1007/s10549-004-7048-0